Asthma treatment

http://www.healasthma.com – . New York Times, The Drug Maker To Settle Suit Copley Pharmaceutical Inc. has agreed to settle a shareholder lawsuit stemming from its recall of an asthma drug that have caused numerous deaths and injuries.The maker of generic drugs has agreed in principle to settle a lawsuit in which shareholders accused the company of misleading them about the extent of its troubles.The proposed . million settlement would require Copley to pay . million to shareholders from its own funds, the company said late Thursday in a statement…. . THE ORLANDO SENTINEL – ASTHMA RECALL Copley Pharmaceutical Co. is recalling its widely used albuterol sulfate inhalation system for asthma sufferers because the solution be contaminated by microbial organisms. This could pose serious problems for people with weak immune systems. Copley sells the solution under its own name and these private brand labels Aligen, Astra, Geneva, Goldline, Harber, Major, Moore, H.L. Moore, Qualitest, Rugby and Schein. (The recall does not involve Copley’s . percent albuterol… . News & Observer, The (Raleigh, NC) – GSK, Wal-Mart sell rescue inhaler Devices use new propellant that replaces ozone-damaging CFC versions Jan. –GlaxoSmithKline has teamed with Wal-Mart, the largest retailer in the world, to tap the market for “green” asthma inhalers. The inhalers contain albuterol, a drug that provides asthma and emphysema sufferers with immediate relief. They are powered by hydrofluoroalkane, or HFA, a more ecologically friendly propellant than chlorofluorocarbons. CFCs damage the Earth’s protective ozone layer.Four drugmakers make HFA rescue inhalers, which on… . FD (FAIR DISCLOSURE) WIRE – Q Sepracor Earnings Conference Call – Final OPERATOR Welcome to Sepracor’s second quarter earnings conference call. Hosting the call today from Sepracor is Mr. Adrian Adams, President and Chief Executive Officer. At this time, all participants have been placed in a listen-only mode, and the floor will be open for your questions following the presentation. (OPERATOR INSTRUCTIONS) It is now my pleasure to turn the floor over to your host, Mr. Adrian Adams. Sir, you begin. ADRIAN ADAMS, PRESIDENT &… . FD (FAIR DISCLOSURE) WIRE – Keynote with Jeffery M. Drazen, M.D. at Scientific American Present Targeted Medicine From Concept To Clinic – Final JEFFREY DRAZEN, EDITOR-IN-CHIEF, NEW ENGLAND JOURNAL OF MEDICINE Thank you, Jeffrey. I will point out that the male pattern baldness has nothing to do with the name “Jeffrey”. One of them is an assigned trait and the other is perhaps genetic. I’m going to be talking about targeted treatment this morning. This is a concept that I think is emerging from the fog, as Jeff just pointed out, and are examples where it is likely to be applicable in the… . ASTHMA, Long-term inhaler use worsen condition, research finds An ingredient found in some inhalers used to treat asthma actually acts to worsen inflammation of the lungs over time, researchers have found. The discovery, presented Tuesday before the annual meeting of the American Academy of Allergy, Asthma and Immunology in San Francisco, helps explain why long-term use of inhalers has proved counterproductive for some patients.”We need to do further studies to understand the mechanisms, but the findings suggest the current… . Researchers finds genes that affect asthma drug effectiveness The Associated Press WASHINGTON — In a step toward an age of “personalized medicines,” researchers have found gene variations that affect the way individual asthma sufferers respond to a drug widely used to control acute attacks.Out of thousands of variations in a single gene, the researchers said they have identified that determine how well asthma patients respond to albuterol, a drug commonly used to prevent or to control acute attacks.The study… . New York Times, The Drug Prices Still Vary Widely Across City, Council Survey Finds Two years after a City Council investigation found widespread disparities in prices for prescription drugs at New York pharmacies, significant variations persist despite new rules requiring wider disclosure of retail drug prices, according to a Council report released yesterday. Many consumers had no idea that by going to some pharmacies, they could buy drugs for as little as a seventh of the price they paid for the same medication elsewhere, the report found. The report faulted the… . DRUG-MAKER SETTLEMENT COULD SPELL RELIEF IN STATE A Birmingham lawyer said at least Alabama residents are eligible for payments as part of a proposed million settlement in a class action lawsuit that charged that a drug company sold contaminated medicine.The accord with Copley Pharmaceuticals Inc. over its asthma drug albuterol must still win the final approval of a federal judge in Cheyenne, Wyo. A hearing has been scheduled for Oct. on the matter.Birmingham attorney David Guin thinks the pact, affecting as many as… . Repository, The (Canton, OH) – Asthma sufferers fret about ban on �rescue� inhalers Asthma sufferers will soon be paying more for increasingly scarce emergency inhalers as part of the price of protecting the environment.By the end of the government says, the makers of albuterol �rescue� inhalers � used by millions of people to reopen airways during asthma attacks � will have to stop using the ozone-destroying chlorofluorocarbon propellants that power the devices.Three decades ago, scientists found that the CFCs… –